Individual dynamics of blood parameters. by Ekaterina A. Bryushkova (13360122)

Subjects:

Baseline clinical characteristics of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Changes in CRP and LDH levels over time. by Ekaterina A. Bryushkova (13360122)

Subjects:

Minimal dataset. by Ekaterina A. Bryushkova (13360122)

Subjects:

The outcome timepoints and the mortality level of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Fx controls the TNF-enhanced Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by U-87 MG cells and neuromediators availability. by Glaucia Vilar-Pereira (686134)

This is the raw data of IHC-1 in Rat. by Yangyang Yin (14323701)

Subjects:

Sequences of the primers for q-PCR. by Yangyang Yin (14323701)

Subjects:

The original gel image underlying Fig 5C blot results. by Te-Hsing Hsu (16973374)

The original gel image underlying Fig 5B blot results. by Te-Hsing Hsu (16973374)

The original gel image underlying Fig 5A blot results. by Te-Hsing Hsu (16973374)

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc... by Mary A. Foutz (20361830)

“…Pharmacokinetic studies indicated a half-life of 2 h, <i>C</i>_max of 35 μM, and no observed adverse effects at 1,000 mg kg^–1 dose in mice. In a Gubra-Amylin (GAN) mouse model of MASH, <b>SHO1122147</b> was efficacious in decreasing body weight and liver triglyceride levels at 200 mg kg^–1 day^–1 without changes in body temperature. …”

Morphology and cell viability in U-87MG, U-251MG, SHSY5Y and N2a cells after treatment with SLCP, BBR and SLCP+BBR. by Panchanan Maiti (1459852)

“…<p>U-87MG and U-251MG cells were grown in EMEM and treated with either SLCP (20 μM), BBR (100 μM) or their combination (in this 1:5 ratio) for 24 h, after which an MTT assay was performed. …”

Temporal change in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Birthweights and gestational ages in neonatal intensive care unit of Fukuoka Tokushukai Hospital. by Hiromi Yamaguchi (2396248)

Subjects:

Indicators of community mobility in Fukuoka prefecture. by Hiromi Yamaguchi (2396248)

Subjects:

Regression analysis to explain IgE in different age groups. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal changes in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal negative correlation between total fertility rate and KD incidence. by Hiromi Yamaguchi (2396248)

Subjects:

IgG and gestational age in neonatal intensive care unit (NICU). by Hiromi Yamaguchi (2396248)

Subjects: